Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6857209rdf:typepubmed:Citationlld:pubmed
pubmed-article:6857209lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:6857209lifeskim:mentionsumls-concept:C0009402lld:lifeskim
pubmed-article:6857209lifeskim:mentionsumls-concept:C0007082lld:lifeskim
pubmed-article:6857209lifeskim:mentionsumls-concept:C1522326lld:lifeskim
pubmed-article:6857209pubmed:issue15lld:pubmed
pubmed-article:6857209pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:6857209pubmed:abstractTextPreoperative CEA value. Dukes stage and recurrence rate have been evaluated in 112 patients with large bowel cancer. Recurrence rate within 24 months was significantly higher (33% vs. 10%, p = 0.01) for preoperative CEA values of more than 5 ng/ml. In patients with moderately or poorly differentiated adenocarcinoma the recurrence rate was nearly 40% if the preoperative CEA value was elevated. Among 13 CEA-detected early recurrences, 3 (23%) have been cured by resection.lld:pubmed
pubmed-article:6857209pubmed:languagegerlld:pubmed
pubmed-article:6857209pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6857209pubmed:citationSubsetIMlld:pubmed
pubmed-article:6857209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6857209pubmed:statusMEDLINElld:pubmed
pubmed-article:6857209pubmed:monthAprlld:pubmed
pubmed-article:6857209pubmed:issn0036-7672lld:pubmed
pubmed-article:6857209pubmed:authorpubmed-author:LargiadèrFFlld:pubmed
pubmed-article:6857209pubmed:authorpubmed-author:HaarD JDJlld:pubmed
pubmed-article:6857209pubmed:authorpubmed-author:JollerHHlld:pubmed
pubmed-article:6857209pubmed:authorpubmed-author:MetzgerUUlld:pubmed
pubmed-article:6857209pubmed:authorpubmed-author:DecurtinsMMlld:pubmed
pubmed-article:6857209pubmed:issnTypePrintlld:pubmed
pubmed-article:6857209pubmed:day16lld:pubmed
pubmed-article:6857209pubmed:volume113lld:pubmed
pubmed-article:6857209pubmed:ownerNLMlld:pubmed
pubmed-article:6857209pubmed:authorsCompleteYlld:pubmed
pubmed-article:6857209pubmed:pagination548-9lld:pubmed
pubmed-article:6857209pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6857209pubmed:meshHeadingpubmed-meshheading:6857209-...lld:pubmed
pubmed-article:6857209pubmed:meshHeadingpubmed-meshheading:6857209-...lld:pubmed
pubmed-article:6857209pubmed:meshHeadingpubmed-meshheading:6857209-...lld:pubmed
pubmed-article:6857209pubmed:meshHeadingpubmed-meshheading:6857209-...lld:pubmed
pubmed-article:6857209pubmed:meshHeadingpubmed-meshheading:6857209-...lld:pubmed
pubmed-article:6857209pubmed:year1983lld:pubmed
pubmed-article:6857209pubmed:articleTitle[Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].lld:pubmed
pubmed-article:6857209pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6857209pubmed:publicationTypeEnglish Abstractlld:pubmed